MDXG

MiMedx Group Inc

MDXG, USA

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

https://www.mimedx.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MDXG
stock
MDXG

Is MiMedx Group, Inc.'s (NASDAQ:MDXG) Recent Stock Performance Tethered To Its Strong Fundamentals? simplywall.st

Read more →
MDXG
stock
MDXG

How (MDXG) Movements Inform Risk Allocation Models news.stocktradersdaily.com

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$12.2

Analyst Picks

Strong Buy

5

Buy

0

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

High

24.70

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

4.52

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

7.01 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Medium

5.25 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

22.34 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.33

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 69.53% of the total shares of MiMedx Group Inc

1.

Essex Woodlands Health Ventures

(19.0561%)

since

2025/06/30

2.

BlackRock Inc

(7.7898%)

since

2025/06/30

3.

Trigran Investments Inc

(5.6708%)

since

2025/06/30

4.

Vanguard Group Inc

(4.7021%)

since

2025/06/30

5.

Paradigm Capital Management, Inc.

(3.0092%)

since

2025/06/30

6.

State Street Corp

(2.3425%)

since

2025/06/30

7.

Vanguard Total Stock Mkt Idx Inv

(2.3344%)

since

2025/07/31

8.

iShares Russell 2000 ETF

(1.9355%)

since

2025/08/31

9.

Geode Capital Management, LLC

(1.9216%)

since

2025/06/30

10.

Dimensional Fund Advisors, Inc.

(1.5432%)

since

2025/06/30

11.

Renaissance Technologies Corp

(1.4246%)

since

2025/06/30

12.

Cannell Capital LLC

(1.4017%)

since

2025/06/30

13.

Punch & Associates Inv Mgmt Inc

(1.3341%)

since

2025/06/30

14.

First Light Asset Management, LLC

(1.3027%)

since

2025/06/30

15.

Millennium Management LLC

(1.131%)

since

2025/06/30

16.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8595%)

since

2025/07/31

17.

Fidelity Small Cap Index

(0.8016%)

since

2025/06/30

18.

Qube Research & Technologies

(0.8014%)

since

2025/06/30

19.

Harbor Capital Advisors Inc

(0.7902%)

since

2025/06/30

20.

Charles Schwab Investment Management Inc

(0.7382%)

since

2025/06/30

21.

Northern Trust Corp

(0.7375%)

since

2025/06/30

22.

Meros Investment Management, LP

(0.7216%)

since

2025/06/30

23.

Morgan Stanley - Brokerage Accounts

(0.7165%)

since

2025/06/30

24.

iShares Russell 2000 Growth ETF

(0.7046%)

since

2025/08/31

25.

Royal Bank of Canada

(0.6344%)

since

2025/06/30

26.

Embark Small Cap Equity Retirement

(0.6011%)

since

2025/07/31

27.

SPDR® S&P Biotech ETF

(0.5186%)

since

2025/08/31

28.

Fidelity Extended Market Index

(0.4335%)

since

2025/07/31

29.

Vanguard Russell 2000 ETF

(0.3806%)

since

2025/07/31

30.

Schwab US Small-Cap ETFâ„¢

(0.3762%)

since

2025/08/30

31.

BlackRock Advantage Small Cap Core Instl

(0.3467%)

since

2025/07/31

32.

DFA US Small Cap I

(0.3281%)

since

2025/07/31

33.

Columbia Sm Cp Val and Inflection Inst

(0.3209%)

since

2025/07/31

34.

State St Russell Sm Cap® Indx SL Cl I

(0.284%)

since

2025/08/31

35.

Columbia Small Cap Value and Inflection

(0.2819%)

since

2025/06/30

36.

Putnam Small Cap Value A

(0.2648%)

since

2025/07/31

37.

Dimensional US Small Cap ETF

(0.2579%)

since

2025/08/29

38.

Isthmus Small Cap Core Equity

(0.2479%)

since

2025/06/30

39.

Vanguard Health Care ETF

(0.2467%)

since

2025/07/31

40.

Putnam Small Cap Value Managed Account

(0.2384%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0.15

EPS Estimate

0.058

EPS Difference

0.092

Surprise Percent

158.6207%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(6)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(8)
GARP
Strong GARP(7.5)
Growth
Moderate Growth(6)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
High Quality(7.5)
Value
Fair Value(5.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.